Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FOLFOX plus CT-011 versus FOLFOX alone in metastatic colorectal cancer to assess safety, tolerability and efficacy; the study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CT-011
• FOLFOX

Snippet

Sponsor: Medivation, Inc. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED